Regulations.gov document
Determination That MEXITIL (Mexiletine Hydrochloride) Capsules, 150 Milligrams, 200…
Notice · FDA-2019-P-2982 · posted Nov 1, 2019
Key facts
| Document ID | FDA-2019-P-2982-0003 |
|---|---|
| Title | Determination That MEXITIL (Mexiletine Hydrochloride) Capsules, 150 Milligrams, 200 Milligrams, and 250 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2019-P-2982 |
| Posted | Nov 1, 2019 |
| Federal Register citation | 84 FR 58722 |
| FR document number | 2019-23923 |
| Comment period opens | Nov 1, 2019 |
| Effective date | Nov 1, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: